Osaka Organic Chemical Industry Ltd. Just Recorded A 7.1% Revenue Beat: Here's What Analysts Think

It's been a sad week for Osaka Organic Chemical Industry Ltd. (TSE:4187), who've watched their investment drop 13% to JP¥5,100 in the week since the company reported its half-year result. It was a workmanlike result, with revenues of JP¥20b coming in 7.1% ahead of expectations, and statutory earnings per share of JP¥337, in line with analyst appraisals. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Osaka Organic Chemical Industry after the latest results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following the latest results, Osaka Organic Chemical Industry's seven analysts are now forecasting revenues of JP¥41.1b in 2026. This would be a credible 5.5% improvement in revenue compared to the last 12 months. Statutory earnings per share are expected to tumble 26% to JP¥286 in the same period. In the lead-up to this report, the analysts had been modelling revenues of JP¥38.9b and earnings per share (EPS) of JP¥252 in 2026. So it seems there's been a definite increase in optimism about Osaka Organic Chemical Industry's future following the latest results, with a nice increase in the earnings per share forecasts in particular.

Check out our latest analysis for Osaka Organic Chemical Industry

With these upgrades, we're not surprised to see that the analysts have lifted their price target 9.8% to JP¥6,423per share. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Osaka Organic Chemical Industry at JP¥7,400 per share, while the most bearish prices it at JP¥5,490. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Osaka Organic Chemical Industry is an easy business to forecast or the the analysts are all using similar assumptions.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Osaka Organic Chemical Industry's rate of growth is expected to accelerate meaningfully, with the forecast 11% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 2.0% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 5.3% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Osaka Organic Chemical Industry is expected to grow much faster than its industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Osaka Organic Chemical Industry's earnings potential next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Osaka Organic Chemical Industry analysts - going out to 2028, and you can see them free on our platform here.

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Osaka Organic Chemical Industry (1 doesn't sit too well with us) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.